Literature DB >> 7037508

Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.

M R Taskinen, E A Nikkilä, T Kuusi, K Harmo.   

Abstract

Serum lipoproteins and the heparin-releasable lipoprotein lipase (LPL) activity of adipose tissue and skeletal muscle were measured in 36 untreated obese patients with Type 2 (insulin-independent) diabetes and the values were compared with those of non-diabetic subjects of similar age, sex and relative body weight. In diabetic men, the LPL activity of adipose tissue was significantly reduced when expressed per tissue weight or per fat cell (p less than 0.01). Diabetic females had slightly but not significantly lower LPL activity in adipose tissue than the non-diabetic females. The muscle LPL activity was similar in diabetic and non-diabetic subjects of both sexes. When the diabetic men were classified according to fasting blood glucose, the patients with high glucose levels had lower adipose tissue LPL activity than those with moderate hyperglycemia. In both diabetic and non-diabetic subjects, there was a significant positive correlation between HDL cholesterol concentrations and adipose tissue LPL activity. It is concluded that Type 2 diabetes influences adipose tissue LPL activity and plasma lipoprotein concentrations and that this effect is superimposed on the similar changes produced by obesity alone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7037508     DOI: 10.1007/bf00253869

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man.

Authors:  E A Nikkilä; M R Taskinen; M Kekki
Journal:  Atherosclerosis       Date:  1978-04       Impact factor: 5.162

2.  Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control.

Authors:  A L Kennedy; T R Lappin; T D Lavery; D R Hadden; J A Weaver; D A Montgomery
Journal:  Br Med J       Date:  1978-10-28

3.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

4.  The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal.

Authors:  R Paisey; R S Elkeles; J Hambley; P Magill
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

5.  Prediction of lean body mass from height and weight.

Authors:  R Hume
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

6.  Insulin-independent diabetes: a defect in the activity of lipoprotein lipase in adipose tissue.

Authors:  K G Taylor; D J Galton; G Holdsworth
Journal:  Diabetologia       Date:  1979-05       Impact factor: 10.122

7.  A micromethod for assay of lipoprotein lipase activity in needle biopsy samples of human adipose tissue and skeletal muscle.

Authors:  M R Taskinen; E A Nikkilä; J K Huttunen; H Hilden
Journal:  Clin Chim Acta       Date:  1980-05-21       Impact factor: 3.786

8.  Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.

Authors:  H J Lisch; S Sailer
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

9.  Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus.

Authors:  G D Calvert; J J Graham; T Mannik; P H Wise; R A Yeates
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  17 in total

1.  Fasting and post-prandial adipose tissue lipoprotein lipase and hormone-sensitive lipase in obesity and type 2 diabetes.

Authors:  G Costabile; G Annuzzi; L Di Marino; C De Natale; R Giacco; L Bozzetto; P Cipriano; C Santangelo; R Masella; A A Rivellese
Journal:  J Endocrinol Invest       Date:  2010-10-04       Impact factor: 4.256

2.  Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.

Authors:  Christophe Marçais; Bruno Verges; Sybil Charrière; Valérie Pruneta; Micheline Merlin; Stéphane Billon; Laurence Perrot; Jocelyne Drai; Agnès Sassolas; Len A Pennacchio; Jamila Fruchart-Najib; Jean-Charles Fruchart; Vincent Durlach; Philippe Moulin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 3.  Lipoprotein alterations in diabetes mellitus.

Authors:  G M Kostner; I Karádi
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

4.  Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone.

Authors:  G D Tan; G Olivecrona; H Vidal; K N Frayn; F Karpe
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

Review 5.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

6.  Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects.

Authors:  E Casiglia; G Zanette; A Mazza; V Donadon; C Donada; A Pizziol; V Tikhonoff; P Palatini; A C Pessina
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

7.  Characterization of lipase activities in obese Pima indians. Decreases with weight reduction.

Authors:  J S Reitman; F C Kosmakos; B V Howard; M R Taskinen; T Kuusi; E A Nikkila
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

Review 8.  Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

Authors:  R Huupponen
Journal:  Med Toxicol       Date:  1987 May-Jun

9.  Lipoprotein lipase and hepatic lipase in Wistar and Sprague-Dawley rat tissues. Differences in the effects of gender and fasting.

Authors:  X Galan; M Llobera; I Ramírez
Journal:  Lipids       Date:  1994-05       Impact factor: 1.880

Review 10.  Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

Authors:  A Melander; P O Bitzén; O Faber; L Groop
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.